Pulmonary hypertension in chronic liver disease.
Pulmonary hypertension develops in approximately 2% of patients with portal hypertension. Diagnosis is often difficult and requires a high degree of clinical suspicion. Treatment of patients with portal and pulmonary hypertension is limited, and mean survival following diagnosis is approximately 15 months. The effect of liver transplantation on the natural history of disease is discussed.
Mandell
M S
MS
Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, USA.
Groves
B M
BM
D002908:Chronic Disease; D004730:Endothelium, Vascular; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications* / Q000175:diagnosis / Q000601:surgery; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality / Q000503:physiopathology; D008107:Liver Diseases / Q000150:complications / Q000503:physiopathology / Q000601:surgery; D016031:Liver Transplantation; D008168:Lung / Q000098:blood supply; D011379:Prognosis; D015996:Survival Rate; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents